Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2002 | 1 |
2003 | 4 |
2010 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.
J Am Acad Dermatol. 2002 Dec;47(6):821-33. doi: 10.1067/mjd.2002.127247.
J Am Acad Dermatol. 2002.
PMID: 12451365
Clinical Trial.
Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts.
Gordon KB, Vaishnaw AK, O'Gorman J, Haney J, Menter A; Alefacept Clinical Study Group.
Gordon KB, et al.
Arch Dermatol. 2003 Dec;139(12):1563-70. doi: 10.1001/archderm.139.12.1563.
Arch Dermatol. 2003.
PMID: 14676071
Clinical Trial.
Item in Clipboard
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.
Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group.
Lebwohl M, et al.
Arch Dermatol. 2003 Jun;139(6):719-27. doi: 10.1001/archderm.139.6.719.
Arch Dermatol. 2003.
PMID: 12810502
Clinical Trial.
Item in Clipboard
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.
Ellis CN, Krueger GG; Alefacept Clinical Study Group.
Ellis CN, et al.
N Engl J Med. 2001 Jul 26;345(4):248-55. doi: 10.1056/NEJM200107263450403.
N Engl J Med. 2001.
PMID: 11474662
Free article.
Clinical Trial.
Item in Clipboard
Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis.
Ortonne JP, Lebwohl M, Em Griffiths C; Alefacept Clinical Study Group.
Ortonne JP, et al.
Eur J Dermatol. 2003 Mar-Apr;13(2):117-23.
Eur J Dermatol. 2003.
PMID: 12695125
Clinical Trial.
Item in Clipboard
Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis.
Finlay AY, Salek MS, Haney J; Alefacept Clinical Study Group.
Finlay AY, et al.
Dermatology. 2003;206(4):307-15. doi: 10.1159/000069942.
Dermatology. 2003.
PMID: 12771471
Clinical Trial.
Item in Clipboard
The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis.
Roberts JL, Ortonne JP, Tan JK, Jaracz E, Frankel E; Alefacept Clinical Study Group.
Roberts JL, et al.
J Am Acad Dermatol. 2010 Jun;62(6):968-78. doi: 10.1016/j.jaad.2009.07.032. Epub 2010 Apr 14.
J Am Acad Dermatol. 2010.
PMID: 20392521
Item in Clipboard
Cite
Cite